Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

6.5%

2 terminated out of 31 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

35%

11 trials in Phase 3/4

Results Transparency

18%

4 of 22 completed with results

Key Signals

4 with results92% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (3)
P 2 (2)
P 3 (5)
P 4 (6)

Trial Status

Completed22
Recruiting4
Unknown3
Terminated2

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 22 completed trials

Clinical Trials (31)

Showing 20 of 20 trials
NCT07309562Phase 3RecruitingPrimary

The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age

NCT03662178Recruiting

Investigating the Structured Use of Ultrasound Scanning for Fetal Growth

NCT00597480Phase 4TerminatedPrimary

Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH)

NCT00537914Phase 4CompletedPrimary

Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA)

NCT05838885Phase 2Completed

A Trial of YPEG-rhGH in Children With Short Stature

NCT04798690Recruiting

Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature

NCT05603936Unknown

Adaption and Testing of the Quality of Life in Short Stature Youth (QoLISSY) Questionnaire for Parents With Children From 0-4

NCT01578135Completed

French National Registry of Children Born Small for Gestational Age Treated With Somatropin

NCT01604395Recruiting

Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children

NCT01110928Completed

Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing

NCT02280031Phase 2CompletedPrimary

Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial.

NCT02964793Not ApplicableUnknownPrimary

Effects of Serial Plotting on Fundal Height Charts on Identification and Outcomes of Small for Gestational Age Infants

NCT02218931Not ApplicableCompleted

ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes

NCT00960128Completed

Observational Prospective Study on Patients Treated With Norditropin®

NCT00184717Phase 3Completed

Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)

NCT01734447Phase 4Completed

Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation

NCT00557336Phase 3Completed

Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age

NCT01245374Phase 4Completed

Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents

NCT00184691Phase 3Completed

Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years

NCT01697644Phase 4Completed

Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation

Scroll to load more

Research Network

Activity Timeline